Neuropace shares owned by Morgan Stanley
Historical chart of Morgan Stanley investment in Neuropace
Tip: Access up to 7 years of quarterly data
All positions including Neuropace held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neuropace by Morgan Stanley
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $29M | 2.6M | 11.14 |
| 2024-12-31 | $28M | 2.5M | 11.19 |
| 2024-09-30 | $17M | 2.5M | 6.97 |
| 2024-06-30 | $19M | 2.5M | 7.56 |
| 2024-03-31 | $33M | 2.5M | 13.20 |
| 2023-12-31 | $25M | 2.5M | 10.31 |
| 2023-09-30 | $23M | 2.4M | 9.73 |
| 2023-06-30 | $11M | 2.4M | 4.49 |
| 2022-12-31 | $3.3M | 2.2M | 1.50 |
| 2022-06-30 | $12M | 2.0M | 5.99 |
| 2022-03-31 | $8.1M | 1.0M | 7.84 |
| 2021-06-30 | $200k | 7.6k | 26.32 |